A Detailed Analysis of the Alzheimer’s Disease Diagnostics & Treatment Market Based on an Expanding Aging Population, and Rising Awareness About the Condition
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 237
Report ID: PMRREP33700
1. Executive Summary
1.1. Global Alzheimer Disease Diagnostics & Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Alzheimer Disease Diagnostics & Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force’s Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Therapeutics
3.3.3.1.1. Cholinesterase Inhibitors
3.3.3.1.2. NMDA Receptor Antagonists
3.3.3.1.3. Manufactured Combination
3.3.3.2. Diagnostics
3.3.3.2.1. Lumbar Diagnostics Test
3.3.3.2.2. CT Scan
3.3.3.2.3. MRI
3.3.3.2.4. EEG
3.3.3.2.5. PET scan
3.4. Market Attractiveness Analysis: Product
3.5. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Distribution Channel
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.5.3.1. Institutional Sales
3.5.3.1.1. Hospitals
3.5.3.1.2. Specialty Clinics
3.5.3.1.3. Diagnostic Centers
3.5.3.2. Retail Sales
3.5.3.2.1. Retail Pharmacies
3.5.3.2.2. Drug Stores
3.5.3.2.3. Online Pharmacies
3.6. Market Attractiveness Analysis: Distribution Channel
4. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Therapeutics
5.5.1.1. Cholinesterase Inhibitors
5.5.1.2. NMDA Receptor Antagonists
5.5.1.3. Manufactured Combination
5.5.2. Diagnostics
5.5.2.1. Lumbar Diagnostics Test
5.5.2.2. CT Scan
5.5.2.3. MRI
5.5.2.4. EEG
5.5.2.5. PET scan
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.6.1. Institutional Sales
5.6.1.1. Hospitals
5.6.1.2. Specialty Clinics
5.6.1.3. Diagnostic Centers
5.6.2. Retail Sales
5.6.2.1. Retail Pharmacies
5.6.2.2. Drug Stores
5.6.2.3. Online Pharmacies
5.7. Market Attractiveness Analysis
6. Europe Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Therapeutics
6.5.1.1. Cholinesterase Inhibitors
6.5.1.2. NMDA Receptor Antagonists
6.5.1.3. Manufactured Combination
6.5.2. Diagnostics
6.5.2.1. Lumbar Diagnostics Test
6.5.2.2. CT Scan
6.5.2.3. MRI
6.5.2.4. EEG
6.5.2.5. PET scan
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.6.1. Institutional Sales
6.6.1.1. Hospitals
6.6.1.2. Specialty Clinics
6.6.1.3. Diagnostic Centers
6.6.2. Retail Sales
6.6.2.1. Retail Pharmacies
6.6.2.2. Drug Stores
6.6.2.3. Online Pharmacies
6.7. Market Attractiveness Analysis
7. East Asia Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Therapeutics
7.5.1.1. Cholinesterase Inhibitors
7.5.1.2. NMDA Receptor Antagonists
7.5.1.3. Manufactured Combination
7.5.2. Diagnostics
7.5.2.1. Lumbar Diagnostics Test
7.5.2.2. CT Scan
7.5.2.3. MRI
7.5.2.4. EEG
7.5.2.5. PET scan
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.6.1. Institutional Sales
7.6.1.1. Hospitals
7.6.1.2. Specialty Clinics
7.6.1.3. Diagnostic Centers
7.6.2. Retail Sales
7.6.2.1. Retail Pharmacies
7.6.2.2. Drug Stores
7.6.2.3. Online Pharmacies
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Therapeutics
8.5.1.1. Cholinesterase Inhibitors
8.5.1.2. NMDA Receptor Antagonists
8.5.1.3. Manufactured Combination
8.5.2. Diagnostics
8.5.2.1. Lumbar Diagnostics Test
8.5.2.2. CT Scan
8.5.2.3. MRI
8.5.2.4. EEG
8.5.2.5. PET scan
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.6.1. Institutional Sales
8.6.1.1. Hospitals
8.6.1.2. Specialty Clinics
8.6.1.3. Diagnostic Centers
8.6.2. Retail Sales
8.6.2.1. Retail Pharmacies
8.6.2.2. Drug Stores
8.6.2.3. Online Pharmacies
8.7. Market Attractiveness Analysis
9. Latin America Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Therapeutics
9.5.1.1. Cholinesterase Inhibitors
9.5.1.2. NMDA Receptor Antagonists
9.5.1.3. Manufactured Combination
9.5.2. Diagnostics
9.5.2.1. Lumbar Diagnostics Test
9.5.2.2. CT Scan
9.5.2.3. MRI
9.5.2.4. EEG
9.5.2.5. PET scan
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.6.1. Institutional Sales
9.6.1.1. Hospitals
9.6.1.2. Specialty Clinics
9.6.1.3. Diagnostic Centers
9.6.2. Retail Sales
9.6.2.1. Retail Pharmacies
9.6.2.2. Drug Stores
9.6.2.3. Online Pharmacies
9.7. Market Attractiveness Analysis
10. Middle East & Africa Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Therapeutics
10.5.1.1. Cholinesterase Inhibitors
10.5.1.2. NMDA Receptor Antagonists
10.5.1.3. Manufactured Combination
10.5.2. Diagnostics
10.5.2.1. Lumbar Diagnostics Test
10.5.2.2. CT Scan
10.5.2.3. MRI
10.5.2.4. EEG
10.5.2.5. PET scan
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.6.1. Institutional Sales
10.6.1.1. Hospitals
10.6.1.2. Specialty Clinics
10.6.1.3. Diagnostic Centers
10.6.2. Retail Sales
10.6.2.1. Retail Pharmacies
10.6.2.2. Drug Stores
10.6.2.3. Online Pharmacies
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Biogen Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. AbbVie, Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Teva Pharmaceuticals Ltd.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Eisai Co.Ltd.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Janssen Pharmaceuticals Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Novartis AG
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Zydus Lifesciences Ltd.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Sun Pharmaceutical Industries Ltd.
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Dr. Reddy's Laboratories Ltd.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Aurobindo Pharma Ltd.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
